# Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants

> **NCT01261117** · NA · COMPLETED · sponsor: **Zekai Tahir Burak Women's Health Research and Education Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **DRUG:** oral ibuprofen

## Key facts

- **NCT ID:** NCT01261117
- **Lead sponsor:** Zekai Tahir Burak Women's Health Research and Education Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-04
- **Final completion:** 2011-06
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2011-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01261117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01261117, "Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01261117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*